Accumulating evidence has suggested that the dysregulation of miRNA is an important factor in the pathogenesis of lung cancer. Here, we demonstrate that miR-335 expression is reduced in non-small cell lung cancer (NSCLC) tumors relative to non- 
revealed that overall 5-year survival rates for NSCLC remain below 15%. 3, 4 The transformer 2 beta homolog (Tra2b), also known as RA301 and SFRS10, is a gene that encodes a serine/arginine-rich (SR)-like nuclear protein. The Tra2b protein belongs to the SR-like protein family and has an RNA recognition motif (RRM) and two RS domains. 5 It has been shown to play an important role in RNA processing and normal tissue development, and is essential for the normal development of the embryo and brain in mice, where Tra2b deficiency results in early embryonic lethality. 6 Furthermore, Tra2b has been reported to be associated with several pathologies, including stroke, tumorigenesis, silicosis, nerve injury and atherosclerosis. 5, 7, 8 The Tra2b protein is now considered to be one of the most important splicing factors that are involved in the progression of several diseases, including cancer. 9 A recent study has shown that Tra2b was upregulated in NSCLC and that this upregulation was correlated with a poor prognosis. 10 Conversely, downregulation of Tra2b inhibited cell proliferation and induced apoptosis of A549 lung carcinoma cells. 10 Based on these findings, the authors of the study speculated that Tra2b might serve as a novel molecular target for the diagnosis and treatment of NSCLC. 10 MicroRNA (miRNA) are a class of small, single-stranded endogenous non-coding RNA comprising 18-22 nucleotides. 11 They regulate gene expression post-transcriptionally through binding to the 3 0 untranslated region (3 0 UTR region) of their target mRNA, inhibiting production of the encoded protein. 12 The differential expression of miRNA in the cells of tumor tissues and normal tissues has been described for many different tumor types. 13, 14 Accumulating evidence has shown that miRNA play an important role in many biological processes, including cell growth, metabolism, differentiation and apoptosis. 15 and further research has demonstrated that they play a vital role in the development of cancers. 11, 15 On this basis, some miRNA may become treatment targets for cancers. Indeed, recent studies in a range of different cancers have shown that dysregulated miRNA can cause tumor initiation, development and metastasis, by regulating the expression of multiple target genes. 16 In particular, studies have shown that the expression of miRNA in NSCLC tissue compared with normal tissues is dysregulated. 17, 18 However, no studies have previously reported a specific correlation between miR-335 expression and NSCLC, and the effects and molecular mechanisms of miR-335 in the pathogenesis of NSCLC are currently unclear. Against this background, we sought to investigate the relationship between the expression of miR-335 and Tra2b in NSCLC tissues and adjacent non-cancerous tissues, and to explore experimentally the roles of miR-335 and Tra2b in the pathogenesis of NSCLC.
| MATERIALS AND METHODS
Ethical approval for the study was sought and granted by the Ethics Committee of the Affiliated Hospital of Nantong University, Jiangsu
Province, China. Written informed consent was obtained from all patients who participated in the study. Forty-eight hours after transfection, the luciferase activity was conducted using the Dual-Luciferase Reporter Assay System (Promega, USA). All experiments were performed in triplicate.
| Protein extraction and western blotting
The total protein content of the transfected and control cells was extracted by mixing with RIPA lysis buffer for 30 minutes on ice.
Protein concentration was determined using a BCA Quantification Kit (Beyotime, Beijing, China). Protein lysates (50 lg) were separated by 12% SDS-PAGE and blotted onto a 0.45-lm PVDF membrane (Millipore, Hercules, CA, USA). The membrane was then incubated with HRP-conjugated secondary antibody (Jackson, USA) at room temperature for 2 hours. Immuno-reactivity of the separated proteins was visualized using the ECL Western Blotting kit (Invitrogen, USA) according to the manufacturer's instructions, using GAPDH as a loading control. Rabbit anti-AKT, anti-pAKT-S473, anti-S6K and anti-pS6K-T389 were purchased from Cell Signaling Technology (Boston, MA, USA). Anti-rabbit IgG-HRP and GAPDH mRB antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All experiments were performed in triplicate.
| Cell viability
To determine the effects of miR-335 on cell viability, A549 cells were seeded in 96-well plates at a density of 6000 cells per well, in 100 lL. After transfection of exogenous miR-335 mimics, miR-335 siRNA or scrambled miRNA for 48 hours, cell viability was assessed using the MTT colorimetric assay. A 10-lL aliquot of 5 mg/mL MTT (Sigma-Aldrich, St. Louis, MO, USA) was added to each well and incubated for 4 hours, after which the MTT solution was removed and dimethyl sulfoxide was added to each well to dissolve the metabolic product. Absorbance was measured at 490 nm using a microplate reader (Thermo Fisher, USA).
| Cell apoptosis
To determine the effects of miR-335 on apoptosis of NSCLC cells, A549 cells were seeded in 6-well plates with a density of 2 9 10 5 per well. When the cells had reached 70% to 80% confluence, they were transfected with miR-335 mimics, miR-335 antagomir or scrambled miRNA. Forty-eight hours after transfection, cells were collected for processing using a Cell Apoptosis Kit (BD Biosciences, San Jose, CA, USA) and sorted to separate out apoptotic cells using a flow cytometer (Beckman Coulter, Brea, CA, USA). Data were processed and analyzed using a Beckman Coulter Epics XL Flow Cytometer.
| Real-time quantitative PCR analysis
The total RNA was isolated from transfected A549 cells using TRIzol 
| Statistical analysis
The survival rate of NSCLC patients in the study sample was calculated using Kaplan-Meier survival analysis. Differences between groups were determined by one-way ANOVA using SPSS Statistics v17.0 (IBM, Armonk, NY, USA). All experiments were performed in triplicate as a minimum and data are expressed as means AE SD.
P < .05 was considered statistically significant. vector increased expression, at both the gene and protein levels ( Figure 4A-C) . 10 As shown in Figure 4D , inhibition of Tra2b significantly inhibited A549 cell growth, a finding that is consistent with results of our previous research. In contrast, overexpression of Tra2b stimulated A549 cell growth, as evidenced by an increase in the ratio of BrdU-positive cells increased ( Figure 4E,F) . We 
| DISCUSSION
The initiation and progression of NSCLC is an extensive pathological process that involves complex alterations in the expression of various oncogenes and tumor suppressor genes that play key roles in cell proliferation and cell apoptosis. In spite of the development of therapeutic approaches for the treatment of NSCLC, such as surgical resection, chemotherapy and radiation therapy, the disease is rarely curable and has a poor prognosis. 20 A deeper understanding of the genes and associated mechanisms involved in the progression of NSCLC is urgently needed to improve current treatments and prognoses. In the present study, we investigated the role of Tra2b and miR-335 in the development of NSCLC. There is an accumulating body of evidence suggesting that miRNA play an important role in tumorigenesis as well as in tumor progression, diagnosis and treatment. 21 Despite the identification of a number of miRNA targets involved in human tumors, in the majority of cases their mechanisms of effect remain unclear. The expression of miR-335 has been shown to be aberrant in tumor tissue from several types of cancer, and is associated with cell proliferation and inflammation. [22] [23] [24] The present study found that miR-335 was 
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